VC firm
CTI Life Sciences Fund
- Investor type
- VC
- Investing status
- Activeas of 2026-09-18Source (opens in a new tab)
- Headquarters
- Montreal, Quebec, Canada
- Founded
- 2006
- Legal name
- CTI Life Sciences Fund
Claim, correct or request removal
Record updated 18 September 2026
About
More than an investor - we are a Company Builder that catalyzes nascent ideas and assets into investable, scalable, and marketable biotech companies.
Investment approach
- Thesis
- Strategic buyers will pay a premium to acquire biotech companies with best-in-class assets or platformSource (opens in a new tab)
- Takes board seats
- Yes
- Board policy
- Shermaine is an active board director of Phenomic AI and Ability Pharma.
- Investing status notes
- CTI Life Sciences Fund Launches Oligon Therapeutics to Pioneer a New Class of Precision siRNA Therapeutics
Locations
- Headquarters
- Montreal, Quebec, Canada
Loading relationship preview